ARCTURUS THERAPEUTICS HLDG I's ticker is and the CUSIP is 03969T909. A total of 4 filers reported holding ARCTURUS THERAPEUTICS HLDG I in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $488 | +57.9% | 19,100 | +76.9% | 0.00% | – |
| Q2 2023 | $309 | -25.0% | 10,800 | -37.2% | 0.00% | – |
| Q1 2023 | $412 | +229.6% | 17,200 | +132.4% | 0.00% | – |
| Q4 2022 | $125 | -99.9% | 7,400 | +4.2% | 0.00% | – |
| Q3 2022 | $105,000 | -53.3% | 7,100 | -50.3% | 0.00% | – |
| Q2 2022 | $225,000 | -59.7% | 14,300 | -30.9% | 0.00% | -100.0% |
| Q1 2022 | $558,000 | -58.9% | 20,700 | -43.6% | 0.00% | 0.0% |
| Q4 2021 | $1,358,000 | +282.5% | 36,700 | +270.7% | 0.00% | – |
| Q3 2021 | $355,000 | +6.0% | 9,900 | 0.0% | 0.00% | – |
| Q2 2021 | $335,000 | -26.2% | 9,900 | +8900.0% | 0.00% | -100.0% |
| Q1 2021 | $454,000 | -78.7% | 110 | -77.6% | 0.00% | -66.7% |
| Q4 2020 | $2,134,000 | -4.9% | 492 | -5.9% | 0.00% | 0.0% |
| Q3 2020 | $2,243,000 | +701.1% | 523 | +771.7% | 0.00% | – |
| Q2 2020 | $280,000 | +536.4% | 60 | +81.8% | 0.00% | – |
| Q1 2020 | $44,000 | +57.1% | 33 | +26.9% | 0.00% | – |
| Q4 2019 | $28,000 | -12.5% | 26 | -18.8% | 0.00% | – |
| Q3 2019 | $32,000 | +3100.0% | 32 | +1500.0% | 0.00% | – |
| Q2 2019 | $1,000 | – | 2 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 5,100 | $122,247 | 0.00% |
| SIMPLEX TRADING, LLC | 17,200 | $412 | 0.00% |
| JANE STREET GROUP, LLC | 32,800 | $786,216 | 0.00% |